HTA community perspectives on the use of patient preference information: lessons learned from a survey with members of HTA bodies.

ABSTRACT: This research sought to assess whether and how patient preference (PP) data are currently used within health technology assessment (HTA) bodies and affiliated organizations involved in technology/drug appraisals and assessments. An exploratory survey was developed by the PP Project Subcommittee of the HTA International Patient and Citizen Involvement Interest Group to gain insight into the use, impact, and role of PP data in HTA, as well as the perceived barriers to its incorporation. Forty members of HTA bodies and affiliated organizations from twelve countries completed the online survey. PP data were reported to be formally considered as part of the HTA evidence review process by 82.5 percent of the respondents, while 39.4 percent reported that most of the appraisals and assessments wit

SUBMITTER: Hiligsmann M 

PROVIDER: S-EPMC11569952 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature